BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Metastatic Breast Cancer

1 post

When breast cancer spreads to other parts of the body, it is called metastatic breast cancer. This is a very serious condition that requires aggressive treatment.

Metastatic breast cancer can occur in any organ or tissue in the body. The most common sites are the lungs, bones, and liver.

Symptoms of metastatic breast cancer vary depending on the location of the tumors. Symptoms may include coughing, chest pain, bone pain, and yellowing of the skin and eyes (jaundice).

If you are diagnosed with metastatic breast cancer, your treatment will depend on the location and extent of the tumors. Treatment options may include chemotherapy, hormonal therapy, and targeted therapy.

Although the prognosis for metastatic breast cancer has improved in recent years, it can still be a serious condition that requires aggressive treatment.

MacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients

Biotech NewsMacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients

  • BioTech Health X
  • September 7, 2021
Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • BioHarvest Sciences (BHST) Grows Revenue 58%
  • Spruce Bio (SPRB) Jumps 65% — From $34 to $225 Overnight
  • NuCana (NCNA) Completes $3.6M Warrant Buyout
  • Galecto (GLTO) Surges 600% Overnight as Traders Swarm the Tiny $5M Biotech
  • Insmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 7, 2025
    BioHarvest Sciences (BHST) Grows Revenue 58%
    • October 7, 2025
    Spruce Bio (SPRB) Jumps 65% — From $34 to $225 Overnight
    • October 7, 2025
    NuCana (NCNA) Completes $3.6M Warrant Buyout
    • October 7, 2025
    Galecto (GLTO) Surges 600% Overnight as Traders Swarm the Tiny $5M Biotech
    • October 3, 2025
    Insmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri
Recent Posts
  • Ocular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials
    • October 3, 2025
  • Novavax (NVAX) Expands $200M Sanofi Deal With Matrix-M Adjuvant
    • October 3, 2025
  • Recursion Pharmaceuticals (RXRX) Could Double With $8 Price Target
    • October 3, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (443)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top